ABCG2- and ABCB1 inhibition using supratherapeutic doses of erlotinib: clinical implications in the treatment of CNS metastases.
| Autor: | van de Stadt, E. A., Yaqub, M., Bahce, I., Hendrikse, N. H. |
|---|---|
| Zdroj: | Journal of Nuclear Medicine; Dec2019, Vol. 60 Issue 12, p1-3, 3p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|